Cakarer Sirmahan, Isler S Cemil, Keskin Basak, Uzun Aysenur, Kocak Berberoglu Hulya, Keskin Cengizhan
Dentistry Faculty, Department of Oral and Maxillofacial Surgery, Istanbul University, Istanbul, Turkey.
J Maxillofac Oral Surg. 2018 Sep;17(3):372-378. doi: 10.1007/s12663-017-1060-5. Epub 2017 Nov 24.
Our aim was to evaluate the clinical outcome of the conservative management of the significantly large benign aggressive lesions of the jaws.
Twenty-two patients were reviewed regarding the demographic, radiographic, and operative findings. Patients were treated by decompression followed by curettage or only with curettage.
No bone grafts were used. Mean follow-up time was 56.2 months. The mandible was more affected than the maxilla. Two of the ameloblastoma, two of the keratocystic odontogenic tumours, and one odontogenic myxoma were recurred.
Despite the low number of the patients, it is concluded that the conservative management is predictable for the management of the benign aggressive lesions in order to reduce morbidity instead of directly performing radical surgery. The life during follow-up is mandatory in the situation of performing conservative surgery for the management of large aggressive lesions with high recurrence rate.
我们的目的是评估颌骨显著大型良性侵袭性病变保守治疗的临床结果。
对22例患者的人口统计学、影像学和手术结果进行了回顾。患者先接受减压治疗,随后进行刮除术,或仅接受刮除术。
未使用骨移植。平均随访时间为56.2个月。下颌骨比上颌骨受影响更严重。2例成釉细胞瘤、2例牙源性角化囊性瘤和1例牙源性黏液瘤复发。
尽管患者数量较少,但得出结论,保守治疗对于良性侵袭性病变的管理是可预测的,以降低发病率,而不是直接进行根治性手术。对于高复发率的大型侵袭性病变进行保守手术时,随访期间的长期观察是必要的。